Advancing Therapeutics through RNA Innovation

RNA technologies hold vast therapeutic potential, offering innovative strategies for the precise treatment of diseases such as cancer and viral infections, while also enabling the development of personalized therapies.

This year’s symposium explores the immense promise of RNA molecules as next-generation therapeutics – extending far beyond the success of mRNA vaccines. RNA-based approaches, particularly antisense oligonucleotides (ASOs), are already making their impact in clinical applications.

• Register now
• Submit an abstract

Topics and highlights

Dive into the latest advancements and gain insights! Through a keynote lecture, invited expert talks and poster presentations, participants will gain insights into current developments in 

• RNA biology and translation
• Enabling platforms for RNA medicines
• RNA manufacturing, formulation, and delivery
• Industry perspectives on RNA innovation
• Fraunhofer innovations shaping RNA therapeutics
   

Featured keynote

• Stefan Engelhardt, Chair of Pharmacology and Toxicology, Technical University Munich (Germany)

Invited expert talks

• Thomas Thum, Hannover Medical School (Germany)
• Johnny Kim, TRON Mainz (Germany)
• Martin Rabel, Cytiva (Germany)
• Sonja Neitzel, Axolabs (Germany)
• Dominik Witzigmann, NanovationTx (Germany)

List to be completed. Details on the talks and additional program highlights will be announced soon.

Why attend?

From foundational RNA biology to advanced delivery systems, this symposium addresses key topics in next-generation therapeutics. 

• Discover emerging technologies and real-world applications shaping the future of therapeutics.
• Gain insights that bridge the gap between research and real-world impact.
• Present your work, engage in discussions, and build your network with fellow experts.

Join our symposium in September 2026! We look forward to welcoming you and to exploring the present and future of RNA therapeutics with you!